Agenda

Session I: Oral Abstracts

Tracks

Thursday, September 7, 2017

1:30 PM - 2:50 PM

Manhattan Ballroom

Speaker

Attendee337

DOT of Sofosbuvir/Ribavirin +/- Peginterferon with Minimal Monitoring for the Treatment of Hepatitis C in People who Use Drugs in Chennai, India (C-DOT)

1:30 PM - 1:45 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Dr Phill Read

Director, Sexual Health and Blood Borne Viruses - SESLHD/ Director, Kirketon Road Centre

South Eastern Sydney LHD

Delivering Direct Acting Antiviral Therapy to Highly Marginalised Populations in an Integrated Primary Health Care Setting

1:45 PM - 2:00 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee861

The PREVAIL Study: Intensive Models of HCV Care for People Who Inject Drugs

2:00 PM - 2:15 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee385

HCV Treatment with Direct-Acting Antivirals in India is Cost-Saving

2:15 PM - 2:30 PM

Abstract

Biography

Attendee417

The Impact Of Alcohol Dependence On Hcv Treatment Initiation In Hiv/Hcv Coinfected Patients Within A Randomized Controlled Trial Investigating A Psychosocial Behavioral Intervention

2:30 PM - 2:35 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee242

All-Oral Anti-HCV Therapy in Injecting Drug Users: Updated Real World Data

2:35 PM - 2:40 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee91

Hepatitis C Treatment by Primary Care Teams in Inner-City Community Health Clinics: A Prospective Cohort Study

2:40 PM - 2:45 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee625

Highly Effective HCV-Therapy and Low Rate of Reinfection in Persons who Inject Drugs and Receive Opioid Agonist Therapy

2:45 PM - 2:50 PM